The prebiotic resistant starch could play an important role in the treatment of non-alcoholic fatty liver disease (NAFLD) in the future. Initial indications suggest that a specially adapted diet with resistant starch not only positively influences the intestinal microbiome but also leads to an alleviation of the disease. This is what an international research team from the “Balance of the Microverse” Cluster of Excellence at the University of Jena, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine (SSPH-SJTUSM) and the Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI) found in a recent study.